ClinicalTrials.Veeva

Menu

Activation Failure of Knee Extensors After Anterior Cruciate Ligament Rupture Depending on the Contraction Mode (QUADFAIL)

L

La Tour Hospital

Status

Not yet enrolling

Conditions

Contraction Mode
Activation Failure
ACL - Anterior Cruciate Ligament Rupture

Study type

Observational

Funder types

Other

Identifiers

NCT06783062
2024-01580

Details and patient eligibility

About

The primary objective of the study is to evaluate the impact of ACL injury and ACL reconstruction on voluntary activation during maximal voluntary contraction (measured by neurophysiological parameters) according to the contraction mode.

The goal is to provide elements of knowledge to clinicians about the mechanisms of the activation failure depending on contraction mode, but also the resulting adapted clinical recommendations for conducting rehabilitation, and particularly for the use of different contraction modes.

The main hypothesis is that activation failure is not equal according to the contraction mode during maximal voluntary contractions and neurophysiological parameters will be decreased in comparison with non-injured subjects.

Secondary objectives are:

  • To analyze the evolution of neurophysiological parameters between sessions interspaced by several months according to the contraction mode.
  • To observe this time evolution depending on the treatment strategy chosen: rehabilitation or surgery plus rehabilitation.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

A. ACL-injured groups (surgically or conservatively treated):

  1. Age between 18 and 50 years
  2. Free, informed consent signed by the participant and the investigator.
  3. Session 1: Delay of 2 to 6 weeks after injury, with a quiet knee (range of motion 110- 0°, minimal effusion, maximal contraction pain ≤ 2/10)
  4. Session 2: Duration of 36 to 42 weeks after injury, with a quiet knee (range of motion 110-0°, minimal effusion, maximal contraction pain ≤ 2/10)
  5. Independent person (Unprotected: under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision)

B. ControlGroup:

  1. Age between 18 and 50 years
  2. Free, informed consent signed by the participant and the investigator.
  3. Sport practitioners: at least once per week practicing activities like collective sports, racket sports, combat sports, skiing, or on-loading activities with changing of directions.
  4. Independent person (Unprotected: under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision)

Exclusion criteria

    1. Subjects fitted with an implanted electronic device such as a cardiac pacemaker 2. Professional athlete 3. Pregnant women 4. Subject with systemic pathology or treatment affecting the musculoskeletal system 5. Subject with a history of neurological pathology or traumatic pathology, or pathology that required orthopedic treatment and/or surgery of the knee, hip and/or lumbar spine 6. Contraindication to isokinetic testing: incapacitating pain, evolving pathological process, non- healed fracture, unbalanced cardiovascular pathology (angina pectoris, arterial hypertension) 7. Contralateral knee injury 8. Subject inability to follow procedures or insufficient knowledge of project language 9. Data acquisition issue or injury during testing

Trial design

60 participants in 3 patient groups

Control
ACL - rehabilitation
ACL - surgery + rehabilitation

Trial contacts and locations

0

Loading...

Central trial contact

François Fourchet, PhD; Simon Barrué-Belou, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems